Results per Page:
A moving target: How spike’s shape determines immune escape in SARS-CoV-2
From the Bloom Lab, Basic Sciences Division
AMOTL2 multitasks to control cell growth and Zika virus infection
From the Overbaugh Lab, Human Biology Division
Fred Hutch researchers discover an unknown soldier in defense against viruses
A gene better known for its role in cancer progression also plays a surprising role in mounting an immune defense against Zika virus
HIV/AIDS research has saved millions of lives globally and led to innovative advances in multiple diseases
Numerous medical advances originate from U.S.-funded HIV research
Experts urge clinical trials network to study infectious disease therapies in immunocompromised patients
More than 6% of Americans are immunocompromised, yet most clinical trials exclude them
Virologist and HIV expert Dr. Michael Emerman retires
Emerman considers mentorship his most important duty in science
Managing mountains of genomic data
Tools invented at Fred Hutch are helping researchers analyze the enormous global database of genomic sequences of the virus that causes COVID-19 to better understand how pathogens evolve and spread
Drs. Keith Jerome and Jesse Bloom elected fellows of American Academy of Microbiology
Fred Hutch researchers’ study of viruses evolves from basic understanding to practical applications
50 years of doing hard things
Founded in 1975 to honor a brother, Fred Hutch Cancer Center pursued bold science, pioneered a cure for blood diseases that changed medicine and became a world-class biomedical research and clinical care institution
Driver’s ed: watching HSV co-infection and recombination in vivo
From the Jerome Lab, Vaccine & Infectious Disease Division
Getting a paw up in the cat-and-mouse game with the COVID-19 virus
Fred Hutch researchers invent method to quickly and safely test thousands of mutations to predict which ones could help the virus escape our defenses
Herpes cure with gene editing makes progress in laboratory studies
Fred Hutch virologists eliminated at least 90% of HSV-1 in preclinical models of oral and genital herpes and reduced viral shedding in a study published in Nature Communications
Virus researchers Cohn and Blanco-Melo win coveted grants
Pew and Searle scholar programs each give a boost to accomplished, early-career scientists
A promising HIV vaccine candidate gets a little help
New strategy stirs a robust response from T cells tracked by McElrath lab
Beyond aesthetics: a visualization tool for better vaccines
From the Bedford lab, Vaccine and Infectious Disease Division
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies
Dr. Larry Corey receives Alexander Fleming Award
Virologist honored by peers for his lifetime achievements against infectious diseases
Researching herpes treatments with 'skin-on-chip' technology
Experimental device grows human skin, infects and treats it; could advance disease modeling in labs
Team of top researchers prepares for endemic COVID-19
$15M Howard Hughes Medical Institute grant shared by 8 scientists at Fred Hutch and UW